Search

Your search keyword '"Haenel, Mathias"' showing total 6 results
Start Over Author "Haenel, Mathias" Journal clinical lymphoma myeloma and leukemia
6 results on '"Haenel, Mathias"'

1. P-277: Carfilzomib, lenalidomide and dexamethasone followed by a second autologous hematopoietic cell transplantation is an effective strategy in first-relapsed multiple myeloma

Author

Tilmont, Remi, primary, Yakoub-Agha, Ibrahim, additional, Eikema, Diderik-Jan, additional, Zinger, Nienke, additional, Haenel, Mathias, additional, Schaap, Nicolaas, additional, Arroyo, Concepcion Herrera, additional, Schuermans, Christine, additional, Bethge, Wolfgang, additional, Engelhardt, Monika, additional, Kuball, Jürgen, additional, Michieli, Mariagrazia, additional, Schub, Natalie, additional, Wilson, Keith M.O., additional, Bourhis, Jean Henri, additional, Mateos, María-Victoria, additional, Rabin, Neil, additional, Jost, Edgar, additional, Kröger, Nicolaus, additional, Moraleda, José Mª, additional, Sica, Simona, additional, Hayden, Patrick J., additional, Beksac, Meral, additional, Schönland, Stefan, additional, and Manier, Salomon, additional

Published
2022
Full Text
View/download PDF

2. Addition of AEG35156 XIAP Antisense Oligonucleotide in Reinduction Chemotherapy Does Not Improve Remission Rates in Patients With Primary Refractory Acute Myeloid Leukemia in a Randomized Phase II Study

Author

Schimmer, Aaron D., Herr, Wolfgang, Hänel, Mathias, Borthakur, Gautham, Frankel, Arthur, Horst, Heinz-August, Martin, Sonja, Kassis, Jeannine, Desjardins, Pierre, Seiter, Karen, Fiedler, Walter, Noppeney, Richard, Giagounidis, Aristoteles, Jacob, Christine, Jolivet, Jacques, Tallman, Martin S., and Koschmieder, Steffen

Published
2011
Full Text
View/download PDF

3. P-177: Predictive factors for severe infections and early death during novel agent-based induction therapy in newly diagnosed, transplant-eligible myeloma: a multicohort analysis from phase III trials

Author

Mai, Elias, primary, Hielscher, Thomas, additional, Bertsch, Uta, additional, Salwender, Hans J., additional, Munder, Markus, additional, Brossart, Peter, additional, Blau, Igor W., additional, Raab, Marc, additional, Duerig, Jan, additional, Giesen, Nicola, additional, Besemer, Britta, additional, Fenk, Roland, additional, Wattad, Mohammed, additional, Haenel, Mathias, additional, von Metzler, Ivana, additional, Graeven, Ullrich, additional, Scheid, Christoph, additional, Weisel, Katja, additional, and Goldschmidt, Hartmut, additional

Published
2021
Full Text
View/download PDF

4. Normalization of serum free light chains during therapy in the MM5 trial predicts prolonged progression free survival and overall survival

Author

Haas, Eva-Maria, primary, Salwender, Hans J., additional, Mai, Elias K., additional, Dürig, Jan, additional, Weisel, Katja, additional, Tichy, Diana, additional, Benner, Axel, additional, Kunz, Christina, additional, Hielscher, Thomas, additional, Bertsch, Uta, additional, Besemer, Britta, additional, Merz, Maximilian, additional, Munder, Markus, additional, Lindemann, Hans-Walter, additional, Hügle-Dörr, Barbara, additional, Giessen, Nicola, additional, Hose, Dirk, additional, Seckinger, Anja, additional, Huhn, Stefanie, additional, Luntz, Steffen, additional, Jauch, Anna, additional, Elmaagacli, Ahmet, additional, Rabold, Bernhard, additional, Fuhrmann, Stephan, additional, Brossart, Peter, additional, Goerner, Martin, additional, Bernhard, Helga, additional, Hoffmann, Martin, additional, Hillengass, Jens, additional, Raab, Marc S., additional, Blau, Igor Wolfgang, additional, Haenel, Mathias, additional, Scheid, Christof, additional, and Goldschmidt, Hartmut, additional

Published
2019
Full Text
View/download PDF

5. Comparison of bortezomib versus lenalidomide maintenance therapy in newly-diagnosed, transplant-eligible multiple myeloma: Results from the phase III GMMG-HD4 and -MM5 trials

Author

Mai, Elias K., primary, Baertsch, Marc-A., additional, Hielscher, Thomas, additional, Bertsch, Uta, additional, Schlenzka, Jana, additional, Salwender, Hans J., additional, Munder, Markus, additional, Fuhrmann, Stephan, additional, Duehrsen, Ulrich, additional, Brossart, Peter, additional, Neben, Kai, additional, Raab, Marc S., additional, Jauch, Anna, additional, Seckinger, Anja, additional, Hose, Dirk, additional, Luntz, Steffen, additional, Sonneveld, Pieter, additional, Lokhorst, Henk, additional, Martin, Hans, additional, Lindemann, Hans-Walter, additional, Blau, Igor Wolfgang, additional, Scheid, Christof, additional, Weisel, Katja, additional, Haenel, Mathias, additional, Duerig, Jan, additional, and Goldschmidt, Hartmut, additional

Published
2019
Full Text
View/download PDF

6. Impact of cytogenetics at relapse on prognosis and benefit from salvage autologous stem cell transplantation in the GMMG phase III trial ReLApsE

Author

Baertsch, Marc-A., primary, Schlenzka, Jana, additional, Hielscher, Thomas, additional, Raab, Marc S., additional, Hillengass, Jens, additional, Müller-Tidow, Carsten, additional, Luntz, Steffen, additional, Jauch, Anna, additional, Hose, Dirk, additional, Seckinger, Anja, additional, Brossart, Peter, additional, Goerner, Martin, additional, Klein, Stefan, additional, Schmidt-Hieber, Martin, additional, Reimer, Peter, additional, Graeven, Ullrich, additional, Fenk, Roland, additional, Haenel, Mathias, additional, Martin, Hans, additional, Lindemann, Hans-Walter, additional, Scheid, Christof, additional, Nogai, Axel, additional, Salwender, Hans J., additional, Noppeney, Richard, additional, Weisel, Katja, additional, and Goldschmidt, Hartmut, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results